Human Formulations

White Soft Parafin IP 13.2%w/w + light liquid Parafin IP 10.2% w/w + Cream Preservativs Methyl Paraben IP 0.114%w/w Propyl Paraben 0.014% w/w

White Soft Parafin IP 13.2%w/w + light liquid Parafin IP 10.2% w/w + Cream Preservativs Methyl Paraben IP 0.114%w/w Propyl Paraben 0.014% w/w is a cream formulated with White Soft Parafin IP 13.2%w/w + light liquid Parafin IP 10.2% w/w + Preservativs Meth

Topical FormulationsOintment & Cream Single Ingredient Cream
Sterile injectable formulation

Product information

Product Line
Human Formulations
Category
Topical Formulations, Ointment & Cream
Dosage Form
Cream
Product Type
Single Ingredient

Available strengths

White Soft Parafin IP 13.2%w/w + light liquid Parafin IP 10.2% w/w + Preservativs Methyl Paraben IP 0.114%w/w Propyl Paraben 0.014% w/w

Description

White Soft Parafin IP 13.2%w/w + light liquid Parafin IP 10.2% w/w + Cream Preservativs Methyl Paraben IP 0.114%w/w Propyl Paraben 0.014% w/w is a cream formulated with White Soft Parafin IP 13.2%w/w + light liquid Parafin IP 10.2% w/w + Preservativs Methyl Paraben IP 0.114%w/w Propyl Paraben 0.014% w/w. The listed active ingredient profile is White Soft Parafin w/w; light liquid Parafin % w/w; Preservativs Methyl Paraben w/w Propyl Paraben % w/w, placing the product in the topical dermatology category. The formulation is a topical dermatology product whose exact indication should follow the approved product label. The dosage form is intended for topical/local application; the exact application site and frequency must follow the approved product instructions. For website cataloguing, the composition, strength, dosage form and formulation characteristics should be displayed prominently and consistently. The product description should remain factual and should not include unapproved cure, superiority, guaranteed-result or broad therapeutic claims. Clinical selection should depend on diagnosis, patient-specific factors, contraindications, concomitant medicines and professional judgement. Prescription status, warnings, interactions, adverse effects and dosing or application instructions must be checked against the current approved product label. Manufacturer, licence, storage, shelf-life, reconstitution where applicable, and market-specific regulatory details should be added only from verified product documentation.
WHO-GMP Sourced
Sterile Supply
Regulatory Documentation
Quality Assured